The female Viagra? Myregyna founder on achieving satisfying sex postmenopause
November 1, 2025
|In Uncategorized
Key takeaways
- Gen X women are driving openness about postmenopausal sexual health and demanding effective, stigma-free solutions.
- Myregyna offers a non-hormonal system using plant stem cell technology to restore vaginal hydration, elasticity, and comfort.
- Awareness of GSM remains low, with many women unaware that safe, science-backed treatments exist for postmenopausal symptoms.
Postmenopausal women do not cease having sex, despite societal perceptions, but it can become more challenging. Approximately 50% of postmenopausal women experience vulvar and vaginal atrophy, which causes symptoms such as dryness, irritation, and pain during intercourse.
Personal Care Insights speaks to cell biologist and founder of Myregyna, Dr. Iona Weir, about the rise of menopausal care, the need for greater awareness of vaginal health, and how Gen X is establishing open conversations about postmenopausal sexual satisfaction.
